Showing results (1-10 of 47) with videos related to
Sort By:
Pageof 5
Prostaglandins, Leukotrienes, and Essential Fatty Acids|August 5, 2003
The cysteinyl leukotriene receptorsJilly F EvansAmerican Journal of Clinical Oncology|August 7, 2003
Rofecoxib (Vioxx), a specific cyclooxygenase-2 inhibitor, is chemopreventive in a mouse model of colon cancerJilly F EvansProstaglandins & Other Lipid Mediators|November 16, 2002
Cysteinyl leukotriene receptorsJilly F EvansEuropean Respiratory Review : an Official Journal of the European Respiratory Society|September 27, 2023
Lost in translation: a neglected mTOR target for lymphangioleiomyomatosisJilly F Evans, Francis X McCormack, Nahum Sonenberg, et al.Trends in Pharmacological Sciences|January 12, 2008
What's all the FLAP about?: 5-lipoxygenase-activating protein inhibitors for inflammatory diseasesJilly F Evans, Andrew D Ferguson, Ralph T Mosley, et al.Biomolecules|December 28, 2019
Inhibition of Growth of TSC2-Null Cells by a PI3K/mTOR Inhibitor but Not by a Selective MNK1/2 InhibitorJilly F Evans, Ryan W Rue, Alexander R Mukhitov, et al.Clinical and Vaccine Immunology : CVI|September 18, 2009
A novel 5-lipoxygenase-activating protein inhibitor, AM679, reduces inflammation in the respiratory syncytial virus-infected mouse eyeAlla Musiyenko, Lucia Correa, Nicholas Stock, et al.ACS Medicinal Chemistry Letters|April 25, 2017
Small Molecule Lysyl Oxidase-like 2 (LOXL2) Inhibitors: The Identification of an Inhibitor Selective for LOXL2 over LOXJohn H Hutchinson, Martin W Rowbottom, David Lonergan, et al.Chest|August 9, 2012
Cysteinyl leukotriene 1 receptor expression associated with bronchial inflammation in severe exacerbations of COPDJie Zhu, Venkata Bandi, Shengyang Qiu, et al.Pharmacological Reviews|July 21, 2011
International Union of Basic and Clinical Pharmacology. LXXXIV: leukotriene receptor nomenclature, distribution, and pathophysiological functionsMagnus Bäck, Sven-Erik Dahlén, Jeffrey M Drazen, et al.Pageof 5